Publication Name	World Journal of Cardiology
Manuscript ID	8557
Country	Slovenia

Received	2013-12-30 11:58
Peer-Review Started	2013-12-30 12:01
To Make the First Decision	2014-02-13 15:55
Return for Revision	2014-02-17 19:33
Revised	2014-03-28 14:45
Second Decision	2014-06-27 17:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-27 18:03
Articles in Press	2014-06-27 18:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-25 16:28
Publish the Manuscript Online	2014-09-28 08:35

ISSN	1949-8462 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Genetics & Heredity
Manuscript Type	Topic Highlights
Article Title	miRNome in myocardial infarction: Future directions and perspective
Manuscript Source	Invited Manuscript
All Author List	Emanuela Boštjančič and Damjan Glavač
Funding Agency and Grant Number
Corresponding Author	Damjan Glavač, PhD, Professor of Human Genetics, Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia. damjan.glavac@mf.uni-lj.si
Key Words	MicroRNAs; Myocardial infarction; Human; Animal models; Biomarkers and targets
Core Tip	MicroRNAs (miRNAs) contribute to various developmental, physiological and pathological processes in the heart. Cardiac diseases show abnormal miRNA regulation. Primary studies of miRNA involvement in cardiac disease analyzed mainly miRNAs that enriched in or specific for cardiomyocytes; however, growing evidence suggests that other cell-type-specific or ubiquitously expressed miRNAs are also involved in cardiovascular disease. miRNAs were found to contribute to the pathogenesis of myocardial infarction (MI) and post-MI. The majority of studies focused on miRNAs in animal models of MI, in human and animal plasma samples of MI (prognostic and diagnostic targets), and on miRNAs as promising therapeutic targets.
Publish Date	2014-09-28 08:35
Citation	Boštjančič E, Glavač D. miRNome in myocardial infarction: Future directions and perspective. World J Cardiol 2014; 6(9): 939-958
URL	http://www.wjgnet.com/1949-8462/full/v6/i9/939.htm
DOI	http://dx.doi.org/10.4330/wjc.v6.i9.939

Full Article (PDF)	WJC-6-939.pdf
Full Article (Word)	WJC-6-939.doc
Manuscript File	8557-Review.docx
Answering Reviewers	8557-Answering reviewers.pdf
Copyright License Agreement	8557-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	8557-Language certificate.pdf
Peer-review Report	8557-Peer review(s).pdf
Scientific Misconduct Check	8557-CrossCheck.jpg
Scientific Editor Work List	8557-Scientific editor work list.pdf